Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lung Neoplasms 22Leukemia, Myeloid, Acute 22Breast Neoplasms 20Neoplasm Metastasis 17Pancreatic Neoplasms 15Multiple Myeloma 14Prostatic Neoplasms 13Melanoma 13Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Lymphoma 11Carcinoma, Renal Cell 11Burkitt Lymphoma 10Triple Negative Breast Neoplasms 9Urinary Bladder Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Myelodysplastic Syndromes 8Mouth Neoplasms 8Glioma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Oropharyngeal Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 7Laryngeal Neoplasms 7Fallopian Tube Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma 7Sarcoma 6Nasopharyngeal Carcinoma 6Endometrial Neoplasms 6

Interventions

selinexor 1pazopanib 1fludarabine phosphate 1fludarabine 1cabozantinib 1atezolizumab 1Specimen Handling 1Proton Therapy 1Mesna 1Ifosfamide 1Doxorubicin 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Clear Cell × Specimen Handling × 30 days × Clear all
NCT04458922 2026-06-02

Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
27 enrolled 16 charts
LymphoidSarcoma

Lymphoma, Follicular, Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡